(Q38093445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Key role of ERK1/2 molecular scaffolds in heart pathology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mauro Sbroggiò

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mara Brancaccio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Guido Tarone

1

1 reference

28 August 2017

Mauro Sbroggiò

2

1 reference

28 August 2017

Mara Brancaccio

3

1 reference

28 August 2017

27 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

4047-4054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00018-013-1321-5

27 February 2020

exact match

0 references

cites work

Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Cardiac hypertrophy: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

The conserved phosphoinositide 3-kinase pathway determines heart size in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

The role of protein kinases in adaptational growth of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Protein kinase cascades in the regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Coordinating ERK/MAPK signalling through scaffolds and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Scaffold proteins of MAP-kinase modules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Scaffold proteins: hubs for controlling the flow of cellular information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Transduction of receptor signals by beta-arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Beta-arrestin-mediated signaling in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Teaching old receptors new tricks: biasing seven-transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Β-arrestin: a signaling molecule and potential therapeutic target for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

IQGAP1 modulates activation of B-Raf

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

IQGAP1 is a scaffold for mitogen-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Morgana and melusin: two fairies chaperoning signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

HSP90 at the hub of protein homeostasis: emerging mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in Mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

GIT1 functions as a scaffold for MEK1-extracellular signal-regulated kinase 1 and 2 activation by angiotensin II and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

G protein coupled receptor kinase 2 interacting protein 1 (GIT1) is a novel regulator of mitochondrial biogenesis in heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1321-5

Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload

21 January 2018

1 reference

12 December 2020

Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis

1 reference

12 December 2020

β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway

1 reference

12 December 2020

Specificity determinants of substrate recognition by the protein kinase DYRK1A

1 reference

12 December 2020

Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice

1 reference

12 December 2020

New druggable targets in the Ras pathway?

1 reference

12 December 2020

10.1007/S00018-013-1321-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23532408%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference